Skip to main content

Table 1 The main features of the included studies on individual miR-106

From: Comprehensive and integrative analysis identifies microRNA-106 as a novel non-invasive biomarker for detection of gastric cancer

First author

Year

Country

Ethnicity

Sample size (case/control)

N

Male/femal (case)

Sample source

Methods

MicroRNA

AUC

Sencitivity (%)

Specificity (%)

QUADAS

Tsujiura et al.

2010

Japan

Asian

69/30

99

NA

Plasma

qRT-PCR

miR-106b

0.721

80.00

63.00

4

Zhou et al.

2010

China

Asian

90/27

117

63/27

Serum

qRT-PCR

miR-106a

0.684

48.15

90.24

5

Cai et al.

2013

China

Asian

90/90

180

66/24

Plasma

qRT-PCR

miR-106b

0.773

66.00

80.00

5

Cui et al.

2013

China

Asian

42/99

141

32/10

Gastric juice

qRT-PCR

miR-106a

0.871

73.80

89.30

5

Shiotani et al.

2013

Japan

Asian

64/64

128

41/23

Serum

qRT-PCR

miR-106b

0.610

55.60

70.30

6

Shiotani et al.

2013

Japan

Asian

62/70

132

47/15

Serum

qRT-PCR

miR-106b

0.700

75.80

51.40

6

Zeng et al.

2014

China

Asian

40/36

76

28/12

Serum

qRT-PCR

miR-106b

0.856

75.00

92.50

5

Hou et al.

2015

China

Asian

80/60

140

42/38

Plasma

qRT-PCR

miR-106a

0.895

77.50

93.80

4

Wang et al.

2017

China

Asian

110/110

220

NA

Serum

qRT-PCR

miR-106a

0.786

62.90

88.5

5

Li et al.

2017

China

Asian

65/65

130

50/15

Plasma

qRT-PCR

miR-106b

0.898

86.20

92.30

5

Yuan et al.

2017

China

Asian

28/28

56

22/6

Tissue

qRT-PCR

miR-106a

0.666

62.50

63.60

6

Yuan et al.

2017

China

Asian

48/22

70

38/10

Plasma

qRT-PCR

miR-106a

0.828

77.10

63.60

6

  1. N number of participants, NA not available, AUC area under the curve, QUADAS quality assessment of diagnostic accuracy studies